ArticlePathogens and global health2022

Immunogenicity of the BNT162b2 COVID-19 vaccine as a third dose (booster) following two doses of different primary series regimens in Thailand.

Nasamon Wanlapakorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.